HCA Healthcare, Inc. $HCA Stock Position Lowered by Robeco Institutional Asset Management B.V.

Robeco Institutional Asset Management B.V. trimmed its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 26.6% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 15,727 shares of the company’s stock after selling 5,686 shares during the quarter. Robeco Institutional Asset Management B.V.’s holdings in HCA Healthcare were worth $6,711,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. BlackRock Inc. purchased a new stake in HCA Healthcare during the 2nd quarter valued at about $5,069,974,000. Legal & General Group Plc purchased a new stake in shares of HCA Healthcare during the 2nd quarter valued at approximately $410,992,000. Jupiter Topco LLC acquired a new position in HCA Healthcare in the second quarter valued at approximately $371,138,000. Wellington Management Group LLP grew its holdings in shares of HCA Healthcare by 20.5% during the 2nd quarter. Wellington Management Group LLP now owns 4,707,473 shares of the company’s stock worth $1,835,397,000 after purchasing an additional 799,761 shares during the period. Finally, Bank of America Corp DE acquired a new stake in shares of HCA Healthcare during the second quarter valued at about $238,457,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Key Headlines Impacting HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Attractive valuation: Zacks identifies HCA as a strong value stock, which may appeal to investors seeking a relatively inexpensive healthcare company with potential for market-beating returns. Here’s Why HCA Healthcare Is a Strong Value Stock
• Positive Sentiment: Defensive investor interest: A broader rotation toward high-quality, defensive companies in healthcare and other essential sectors could provide a supportive backdrop for HCA stock. Defensive Rotation Toward Quality Companies
• Positive Sentiment: Expansion in Florida: Cape Coral approved $31 million in incentives for a planned $300 million HCA hospital, supporting the company’s long-term market expansion and future capacity. Cape Coral Approves Incentives for HCA Hospital
• Neutral Sentiment: Upcoming earnings catalyst: HCA is scheduled to report third-quarter results around October 27. Investors are focused on admissions, occupancy, inpatient revenue and other operating metrics, with the report likely to determine the stock’s next significant move. HCA Third-Quarter Earnings Preview
• Neutral Sentiment: Workforce investment: HCA opened a clinical training center in Gainesville, which may strengthen its healthcare staffing pipeline but is unlikely to materially affect near-term earnings. HCA Opens Clinical Training Center
• Negative Sentiment: Mixed earnings outlook: Higher admissions, occupancy and inpatient revenue could help third-quarter results, but rising costs and fewer outpatient surgeries may pressure margins and temper investor expectations. Will HCA Earnings Benefit From Higher Admissions?

HCA Healthcare Stock Performance

Shares of HCA stock opened at $469.45 on Friday. The stock has a market cap of $101.64 billion, a PE ratio of 15.72, a P/E/G ratio of 1.58 and a beta of 1.10. HCA Healthcare, Inc. has a 1 year low of $353.99 and a 1 year high of $556.52. The stock has a fifty day moving average price of $431.58 and a 200 day moving average price of $418.97.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Friday, July 24th. The company reported $7.59 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.56 by $0.03. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The company had revenue of $20.23 billion during the quarter, compared to analysts’ expectations of $19.76 billion. During the same quarter in the previous year, the business posted $6.84 earnings per share. The firm’s quarterly revenue was up 8.7% compared to the same quarter last year. As a group, equities research analysts predict that HCA Healthcare, Inc. will post 29.51 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several research firms recently issued reports on HCA. Weiss Ratings upgraded HCA Healthcare from a “hold (c+)” rating to a “buy (b-)” rating in a report on Thursday, October 8th. Raymond James Financial set a $528.00 price target on HCA Healthcare in a report on Tuesday, July 7th. JPMorgan Chase & Co. cut their price target on shares of HCA Healthcare from $490.00 to $425.00 and set a “neutral” rating on the stock in a research note on Thursday, August 20th. TD Cowen raised their target price on shares of HCA Healthcare from $431.00 to $460.00 and gave the stock a “buy” rating in a research report on Monday, October 12th. Finally, Wells Fargo & Company upped their price objective on HCA Healthcare from $369.00 to $381.00 and gave the company an “equal weight” rating in a research note on Monday, August 3rd. Sixteen equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, HCA Healthcare currently has a consensus rating of “Moderate Buy” and an average target price of $467.61.

HCA Healthcare Company Profile

HCA Healthcare, Inc is a healthcare services company that operates hospitals, ambulatory surgery centers, emergency care facilities, physician practices and other healthcare sites. Its facilities provide a broad range of services, including acute and emergency care, surgery, cardiology, oncology, women’s and children’s services, behavioral health and outpatient care.

The company serves patients primarily across the United States through a network of healthcare facilities in numerous states.